235 related articles for article (PubMed ID: 15583817)
1. Circulating soluble tumour necrosis factor receptors in patients with epidermodysplasia verruciformis as compared to patients with cutaneous tumours in the general population.
Malejczyk M; Józwiak J; Jablonska S; Pfister H; Majewski S; Malejczyk J
Oncol Rep; 2005 Jan; 13(1):151-5. PubMed ID: 15583817
[TBL] [Abstract][Full Text] [Related]
2. The role of soluble TNF receptors for TNF-alpha in uveitis.
Sugita S; Takase H; Taguchi C; Mochizuki M
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3246-52. PubMed ID: 17591895
[TBL] [Abstract][Full Text] [Related]
3. Reduction of plasma levels of soluble tumor necrosis factor and interleukin-2 receptors by means of a novel immunoadsorption column.
Lentz M; Kumar K
Ther Apher Dial; 2008 Dec; 12(6):491-9. PubMed ID: 19140848
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of epidermodysplasia verruciformis-associated human papillomavirus DNA in actinic keratoses of the immunocompetent population.
Pfister H; Fuchs PG; Majewski S; Jablonska S; Pniewska I; Malejczyk M
Arch Dermatol Res; 2003 Dec; 295(7):273-9. PubMed ID: 14618345
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis.
Glossop JR; Dawes PT; Nixon NB; Mattey DL
Arthritis Res Ther; 2005; 7(6):R1227-34. PubMed ID: 16277675
[TBL] [Abstract][Full Text] [Related]
6. Lack of soluble TNF-receptors in women with recurrent spontaneous abortion and possibility for its correction.
Chernyshov VP; Vodyanik MA; Pisareva SP
Am J Reprod Immunol; 2005 Nov; 54(5):284-91. PubMed ID: 16212650
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of circulating chromogranin A and soluble tumor necrosis factor receptors in advanced nonsmall cell lung cancer.
Gregorc V; Spreafico A; Floriani I; Colombo B; Ludovini V; Pistola L; Bellezza G; Viganò MG; Villa E; Corti A
Cancer; 2007 Aug; 110(4):845-53. PubMed ID: 17599769
[TBL] [Abstract][Full Text] [Related]
8. Three measures of tumor necrosis factor alpha activity and insulin resistance in nonobese Japanese type 2 diabetic patients.
Ohya M; Taniguchi A; Fukushima M; Nakai Y; Kawasaki Y; Nagasaka S; Kuroe A; Taki Y; Yoshii S; Hosokawa M; Inagaki N; Seino Y
Metabolism; 2005 Oct; 54(10):1297-301. PubMed ID: 16154427
[TBL] [Abstract][Full Text] [Related]
9. Serum-soluble tumor necrosis factor receptor 2 (sTNF-R2) level determines clinical outcome in patients with aggressive non-Hodgkin's lymphoma.
Goto N; Tsurumi H; Takemura M; Hara T; Sawada M; Kasahara S; Kanemura N; Yamada T; Shimizu M; Takahashi T; Tomita E; Seishima M; Takami T; Moriwaki H
Eur J Haematol; 2006 Sep; 77(3):217-25. PubMed ID: 16856931
[TBL] [Abstract][Full Text] [Related]
10. Comparing Type D personality and older age as correlates of tumor necrosis factor-alpha dysregulation in chronic heart failure.
Denollet J; Vrints CJ; Conraads VM
Brain Behav Immun; 2008 Jul; 22(5):736-43. PubMed ID: 18068948
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of sTNF-R1, sTNF-R2 and CXCL9 correlate with disease activity in adult type paracoccidioidomycosis.
Lyon AC; Teixeira MM; Araújo SA; Pereira MC; Pedroso ER; Teixeira AL
Acta Trop; 2009 Mar; 109(3):213-8. PubMed ID: 19083989
[TBL] [Abstract][Full Text] [Related]
12. [Level of soluble tumor necrosis factor receptor type I in patients with systemic scleroderma].
Alekperov RT; Timchenko AV; Samsonov MIu; Guseva NG; Nasonov EL
Ter Arkh; 2004; 76(5):11-5. PubMed ID: 15230124
[TBL] [Abstract][Full Text] [Related]
13. Expression of tumor necrosis factor-alpha and its soluble receptors in betel-quid-chewing patients at different stages of treatment for oral squamous cell carcinoma.
Su TR; Chang KL; Lee CH; Chen CH; Yang YH; Shieh TY
Oral Oncol; 2004 Sep; 40(8):804-10. PubMed ID: 15288835
[TBL] [Abstract][Full Text] [Related]
14. Cytokines and heart rate variability in patients with chronic heart failure.
Straburzyńska-Migaj E; Ochotny R; Wachowiak-Baszyńska A; Straburzyńska-Lupa A; Leśniewska K; Wiktorowicz K; Cieśliński A
Kardiol Pol; 2005 Nov; 63(5):478-85; discussion 486-7. PubMed ID: 16362851
[TBL] [Abstract][Full Text] [Related]
15. [Soluble tumor necrosis factor receptor-I, II (sTNF-RI, -RII)].
Takemura M; Saito K; Sato M; Seishima M
Nihon Rinsho; 2010 Jul; 68 Suppl 7():183-6. PubMed ID: 20963863
[No Abstract] [Full Text] [Related]
16. Serum soluble TNF receptor I and II levels correlate with disease activity in IBD patients.
Spoettl T; Hausmann M; Klebl F; Dirmeier A; Klump B; Hoffmann J; Herfarth H; Timmer A; Rogler G
Inflamm Bowel Dis; 2007 Jun; 13(6):727-32. PubMed ID: 17260368
[TBL] [Abstract][Full Text] [Related]
17. Mutation and abnormal expression of the p53 gene in the viral skin carcinogenesis of epidermodysplasia verruciformis.
Padlewska K; Ramoz N; Cassonnet P; Riou G; Barrois M; Majewski S; Croissant O; Jablonska S; Orth G
J Invest Dermatol; 2001 Oct; 117(4):935-42. PubMed ID: 11676835
[TBL] [Abstract][Full Text] [Related]
18. [Studies on the production of epidermal cytokines after UVB irradiation in patients with epidermodysplasia verruciformis].
Majewski S; Malejczyk J; Urbanski A; Schwarz T; Malejczyk M; Misiewicz J; Rudnicka L; Szymańczyk J; Luger TA; Jabłońska S
Przegl Dermatol; 1990; 77(6):389-91. PubMed ID: 2287740
[TBL] [Abstract][Full Text] [Related]
19. Four familial cases of epidermodysplasia verruciformis: mother and three sons.
Robati RM; Marefat A; Saeedi M; Rahmati-Roodsari M; Asadi-Kani Z
Dermatol Online J; 2009 Apr; 15(4):8. PubMed ID: 19450401
[TBL] [Abstract][Full Text] [Related]
20. Dietary fat intake and proinflammatory cytokine levels in patients with heart failure.
Lennie TA; Chung ML; Habash DL; Moser DK
J Card Fail; 2005 Oct; 11(8):613-8. PubMed ID: 16230265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
